Lewis James S, Herrera Monica, Wickes Brian, Patterson Jan E, Jorgensen James H
Department of Pharmacy, University Health System, San Antonio, TX, USA.
Antimicrob Agents Chemother. 2007 Nov;51(11):4015-21. doi: 10.1128/AAC.00576-07. Epub 2007 Aug 27.
CTX-M-type extended-spectrum beta-lactamases (ESBLs) have become increasingly common worldwide, with the notable exception of the United States, where TEM- and SHV-type ESBLs have appeared to predominate. We have noted the emergence of ESBLs in our health care system (the University Health System in San Antonio, TX), especially in Escherichia coli isolates, that preferentially hydrolyze cefotaxime rather than ceftazidime, suggesting the possibility of CTX-M-type enzymes. Microbiology laboratory records were reviewed to identify ESBL-producing isolates and to compare the diameters of ceftazidime disk diffusion zones of inhibition to cefotaxime zone diameters. All isolates had been initially detected and confirmed using the procedures recommended by the Clinical and Laboratory Standards Institute. A total of 94 stored ESBL-producing isolates recovered between January 2000 and June 2006 (predominately from blood and normally sterile fluids) were retrieved for further study and screened using PCR primers specific for the presence of CTX-M, TEM, and SHV ESBLs. Only small numbers of retained ESBL-producing isolates were available for study in 2000 and 2002. The percentages of available ESBL-producing organisms in the following years were found to produce CTX-M enzymes: 2000, 25%; 2001, 10%; 2002, 0%; 2003, 60%; 2004, 69%; 2005, 89%; and 2006, 70%. The most common CTX-M-type ESBL was CTX-M-15, followed by CTX-M-16, CTX-M-8, and CTX-M-14. Comparing the disk diffusion zone diameters of cefotaxime and ceftazidime was helpful with the initial recognition of CTX-M-producing E. coli, which had an average cefotaxime zone diameter 7 mm smaller than the ceftazidime zone. However, comparing ceftazidime and cefotaxime zones for CTX-M-producing Klebsiella spp. was not helpful with initial recognition. CTX-M enzymes were also identified in Proteus mirabilis, Enterobacter spp., and Morganella morganii. Based on pulsed-field gel electrophoresis typing of the E. coli isolates, the CTX-M-producing isolates did not represent the spread of a single clone in the institution or in the community. In conclusion, CTX-M-type ESBLs are now the most common ESBL type isolated from patients in our health care system and may also be present but unrecognized in other U.S. locales.
CTX-M型超广谱β-内酰胺酶(ESBLs)在全球范围内日益常见,但美国是个显著例外,在美国,TEM型和SHV型ESBLs似乎占主导地位。我们注意到在我们的医疗系统(德克萨斯州圣安东尼奥市的大学健康系统)中ESBLs的出现,尤其是在大肠杆菌分离株中,这些分离株优先水解头孢噻肟而非头孢他啶,提示可能存在CTX-M型酶。回顾微生物学实验室记录以识别产ESBLs的分离株,并比较头孢他啶纸片扩散抑菌圈直径与头孢噻肟抑菌圈直径。所有分离株最初均按照临床和实验室标准协会推荐的程序进行检测和确认。共检索到2000年1月至2006年6月期间收集的94株产ESBLs的储存分离株(主要来自血液和通常无菌的体液)用于进一步研究,并使用针对CTX-M、TEM和SHV ESBLs存在的PCR引物进行筛查。2000年和2002年仅有少量留存的产ESBLs分离株可供研究。发现随后几年中可用的产ESBLs微生物产生CTX-M酶的百分比分别为:2000年,25%;2001年,10%;2002年,0%;2003年,60%;2004年,69%;2005年,89%;2006年,70%。最常见的CTX-M型ESBL是CTX-M-15,其次是CTX-M-16、CTX-M-8和CTX-M-14。比较头孢噻肟和头孢他啶的纸片扩散抑菌圈直径有助于初步识别产CTX-M的大肠杆菌,其头孢噻肟抑菌圈平均直径比头孢他啶抑菌圈小7毫米。然而,比较产CTX-M的克雷伯菌属的头孢他啶和头孢噻肟抑菌圈对初步识别并无帮助。在奇异变形杆菌、肠杆菌属和摩根摩根菌中也鉴定出了CTX-M酶。基于大肠杆菌分离株的脉冲场凝胶电泳分型,产CTX-M的分离株在机构或社区中并不代表单一克隆的传播。总之,CTX-M型ESBLs现在是我们医疗系统中从患者分离出的最常见的ESBL类型,在美国其他地区可能也存在但未被识别。